Brief: Aeon Biopharma Announces Execution Of Exchange Agreement With Daewoong
15/12/2025 21:41
Dec 15 (Reuters) - Aeon Biopharma Inc AEON.A: AEON BIOPHARMA ANNOUNCES EXECUTION OF EXCHANGE AGREEMENT WITH DAEWOONG AEON BIOPHARMA INC - CO AND DAEWOONG EXECUTE $15 MILLION NOTES EXCHANGE AGREEMENT PLUS ACCRUED INTEREST INTO NEW EQUITY AEON BIOPHARMA INC - EXCHANGE TO ELIMINATE OVER 90% OF AEON'S OUTSTANDING DEBT Source text: ID:nGNX5fNkP3 Further company coverage: AEON.A ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Aeon Biopharma
See all newsBrief: Aeon Biopharma Reports bpd Type 2A Meeting With FDA And Shareholder Approval Of The November Transactions
Brief: Aeon Biopharma Announces Execution Of Exchange Agreement With Daewoong
Brief: Aeon Biopharma Announces First Closing Of Pipe Investment And Provides Update On FDA Type 2A Meeting Scheduling
Brief: Aeon Biopharma Announces FDA bpd Type 2A Meeting For Abp-450 On November 19
Brief: Aeon Biopharma Announces CEO Transition